The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures

British Journal of Dermatology

Volumn 140, Issue 5, 1999, Pages 887-890

  Gupta, G ^a   Long, J ^a   Tillman, D M ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Dermatologists global assessment; Narrowband ultraviolet B; Psoriasis area and severity index; Psoriasis disability index; Psoriasis outcome measures

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISABILITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; SCORING SYSTEM; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0033004228     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02820.x     Document Type: Article

References (21)

1. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
2. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195-201.
3. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-44.
4. British Photodermatology Group. An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996). Br J Dermatol 1997; 137: 327-30.
5. Storbeck K, Hölzle E, Schürer N et al. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993; 28: 227-31.
6. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998; 138: 96-100.
7. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
8. Marks R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125: 235-40.
9. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991; 124: 565-70.
10. van de Kerkhof PCM. On the limitations of the psoriasis area and severity index (PASI). (Letter.) Br J Dermatol 1992; 126: 205.
11. McKenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol 1996; 34: 534-8.
12. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990; 123: 751-6.
13. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-14.
14. Salek MS, Finlay AY. Cyclosporin improves quality of life in psoriasis - does this matter? Br J Dermatol 1993; 129 (Suppl. 42): 32 (Abstr.).
15. Finlay AY, Kelly SE. Psoriasis - an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
16. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127: 13-17.
17. Parry EJ, Tillman DM, Long J, MacKie RM. Audit of UVB phototherapy in the treatment of psoriasis. Br J Dermatol 1995: 133 (Suppl. 45): 16 (Abstr.).
18. van Weelden H, de Baart la Faille H, Young E. van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
19. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-6.
20. Picot E, Meunier L, Picot-Debeze MC et al. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992; 127: 509-12.
21. Kent G, Al-Abadie M. The psoriasis disability index - further analysis. Clin Exp Dermatol 1993; 18: 414-16.